U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07513116) titled 'Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening' on April 01.
Brief Summary: To learn whether an eating pattern called intermittent fasting (IF) is tolerable and feasible for individuals at high risk of pancreatic cancer and whether IF is associated with changes in biological markers, including metabolic, inflammatory, microbiome, and imaging-related markers.
Study Start Date: Sept. 17, 2026
Study Type: INTERVENTIONAL
Condition:
Evaluating
Intermittent Fasting
Pancreatic Cancer
Intervention:
OTHER: intermittent fasting
They will fast for 16 consecutive hours each day and h...